The telehealth company Hims & Hers is adding Zepbound and generic liraglutide to its offering of weight-loss drugs.

Shares of Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) gapped down before the market opened on Wednesday after an insider sold shares in the company. The stock had previously closed at ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Edgewise Therapeutics (EWTX – Research Report), ...

Novo Nordisk is licensing a drug called LX9851 from Lexicon Pharmaceuticals for up to $75 million in upfront and near-term ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Thermo Fisher Scientific TMO has unveiled its latest customer-centric innovation, the Thermo Scientific Krios 5 Cryo-Transmission Electron Microscope (TEM). The next-generation atomic-resolution ...

As the U.S. stock market grapples with volatility driven by escalating trade tensions and significant index declines, investors are increasingly seeking stability amid uncertainty. In this climate, ...

In the wake of recent market turbulence sparked by new tariffs, U.S. indices have experienced significant declines, highlighting the volatility and uncertainty that currently characterize the ...

The event to raise funds for mental health services in the Cedar Valley is from 7 to 9 a.m. May 9 at Bien VenU Event Center ...

IPO watch - Network software firm Fatpipe (FATN) is expected to price its IPO and start trading. Blocks of shares of KinderCare ( KLC ), Click Holdings ( CLIK ), and Upstream Bio ( UPB) move past ...